These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12077074)

  • 1. Serotonergic modulation of visceral sensation: lower gut.
    Camilleri M
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i81-6. PubMed ID: 12077074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic modulation of visceral sensation: upper gastrointestinal tract.
    Tack J; Sarnelli G
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i77-80. PubMed ID: 12077073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications.
    Talley NJ
    Aliment Pharmacol Ther; 1992 Jun; 6(3):273-89. PubMed ID: 1600046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
    De Ponti F; Tonini M
    Drugs; 2001; 61(3):317-32. PubMed ID: 11293643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally acting agents and visceral sensitivity.
    Fioramonti J; Bueno L
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i91-5. PubMed ID: 12077076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tegaserod and other serotonergic agents: what is the evidence?
    Chey WD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serotonin may be the key to the treatment of "irritable bowel disease"].
    Sjövall H
    Lakartidningen; 2001 May; 98(18):2166-71. PubMed ID: 11402594
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?
    Maxton DG; Morris J; Whorwell PJ
    Aliment Pharmacol Ther; 1996 Aug; 10(4):595-9. PubMed ID: 8853764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensation and gas dynamics in functional gastrointestinal disorders.
    Malagelada JR
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i72-5. PubMed ID: 12077071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.
    Kindt S; Tack J
    Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():32-9. PubMed ID: 17620086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin and the GI tract.
    Hasler WL
    Curr Gastroenterol Rep; 2009 Oct; 11(5):383-91. PubMed ID: 19765366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy: non-serotonergic mechanisms.
    Spiller R
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i87-90. PubMed ID: 12077075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapies in the treatment of irritable bowel syndrome.
    Berrada D; Lembo T
    Expert Opin Investig Drugs; 2003 Apr; 12(4):635-45. PubMed ID: 12665418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: serotonergic modulators in the treatment of irritable bowel syndrome--influence on psychiatric and gastrointestinal symptoms.
    Kilkens TO; Honig A; Rozendaal N; Van Nieuwenhoven MA; Brummer RJ
    Aliment Pharmacol Ther; 2003 Jan; 17(1):43-51. PubMed ID: 12492731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
    Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ
    Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sex and gender on irritable bowel syndrome.
    Heitkemper M; Jarrett M; Bond EF; Chang L
    Biol Res Nurs; 2003 Jul; 5(1):56-65. PubMed ID: 12886671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.